| Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain M Glass, RLM Faull, M Dragunow Neuroscience 77 (2), 299-318, 1997 | 1154 | 1997 |
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor M Glass, CC Felder Journal of Neuroscience 17 (14), 5327-5333, 1997 | 756 | 1997 |
| Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor NE Buckley, KL McCoy, É Mezey, T Bonner, A Zimmer, CC Felder, ... European journal of pharmacology 396 (2-3), 141-149, 2000 | 681 | 2000 |
| The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in … M Glass, M Dragunow, RLM Faull Neuroscience 97 (3), 505-519, 2000 | 615 | 2000 |
| Cannabinoid receptors and their endogenous agonists CC Felder, M Glass Annual review of pharmacology and toxicology 38 (1), 179-200, 1998 | 480 | 1998 |
| Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? CS Kearn, K Blake-Palmer, E Daniel, K Mackie, M Glass Molecular pharmacology 67 (5), 1697-1704, 2005 | 420 | 2005 |
| Agonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptors M Glass, JK Northup Molecular pharmacology 56 (6), 1362-1369, 1999 | 378 | 1999 |
| The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration JC Ashton, M Glass Current neuropharmacology 5 (2), 73-80, 2007 | 327 | 2007 |
| LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation CC Felder, KE Joyce, EM Briley, M Glass, KP Mackie, KJ Fahey, ... Journal of Pharmacology and Experimental Therapeutics 284 (1), 291-297, 1998 | 305 | 1998 |
| Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences JM McPartland, M Glass, RG Pertwee British journal of pharmacology 152 (5), 583-593, 2007 | 253 | 2007 |
| Loss of cannabinoid receptors in the substantia nigra in Huntington's disease M Glass, RLM Faull, M Dragunow Neuroscience 56 (3), 523-527, 1993 | 250 | 1993 |
| Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity M Soethoudt, U Grether, J Fingerle, TW Grim, F Fezza, L De Petrocellis, ... Nature communications 8 (1), 1-14, 2017 | 218 | 2017 |
| CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids SD McAllister, M Glass Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 66 (2-3), 161-171, 2002 | 202 | 2002 |
| Evolutionary origins of the endocannabinoid system JM McPartland, I Matias, V Di Marzo, M Glass Gene 370, 64-74, 2006 | 200 | 2006 |
| Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and … SD Banister, M Longworth, R Kevin, S Sachdev, M Santiago, J Stuart, ... ACS Chemical Neuroscience 7 (9), 1241-1254, 2016 | 184 | 2016 |
| The endocannabinoid system as a target for the treatment of neurodegenerative disease EL Scotter, ME Abood, M Glass British journal of pharmacology 160 (3), 480-498, 2010 | 181 | 2010 |
| Cannabis, cannabinoids and reproduction B Park, JM McPartland, M Glass Prostaglandins, leukotrienes and essential fatty acids 70 (2), 189-197, 2004 | 171 | 2004 |
| Pharmacology of indole and indazole synthetic cannabinoid designer drugs ab-fubinaca, adb-fubinaca, ab-pinaca, adb-pinaca, 5f-ab-pinaca, 5f-adb-pinaca, adbica, and 5f-adbica SD Banister, M Moir, J Stuart, RC Kevin, KE Wood, M Longworth, ... ACS chemical neuroscience 6 (9), 1546-1559, 2015 | 168 | 2015 |
| Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 SD Banister, J Stuart, RC Kevin, A Edington, M Longworth, SM Wilkinson, ... ACS chemical neuroscience 6 (8), 1445-1458, 2015 | 168 | 2015 |
| Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain JC Ashton, RMA Rahman, SM Nair, BA Sutherland, M Glass, I Appleton Neuroscience letters 412 (2), 114-117, 2007 | 160 | 2007 |
